VEGFA and wet macular degeneration: Applications of mLP-CRISPR that targeted vascular endothelial growth factor A (Vegfa) in a mouse model of age-related wet macular degeneration reduced Vegfa expression by 44% and reduced choroidal neo-vascularization after a single subretinal injection [59].